Category: Featured

Patenting the Microbiome – Part 2: Microbiome IP Panel, 2017 BIO Convention

This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below.  Given the increasing focus on microbiome technologies for better, safer therapies, and critical importance of Intellectual Property (IP) protection for their full commercialization, it is great to see the 2017 […]




Click here for reuse options!
Copyright 2017 Biotechblog

Integrate DrugPatentWatch Into Your Application or Data Store

Get Customized Access to DrugPatentWatch’s Rich Database DrugPatentWatch provides deep actionable business intelligence on small-molecule drugs and the 1.3 million global patents and applications covering them. DrugPatentWatch was founded in 2002, and has served large and small companies throughout the biopharmaceutical value chain. The platform has also been cited by CNN, NEJM, Nature Journals, and […]




Click here for reuse options!
Copyright 2017 Biotechblog

Patenting the Microbiome

This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. In recognition of World IP Day, I thought it would be nice to share a hopeful update relating to patentability of emerging Microbiome technologies holding great promise for patients […]




Click here for reuse options!
Copyright 2017 Biotechblog

New features from DrugPatentWatch – Bulk API sources and clinical trials

After months of development and feedback from customers, DrugPatentWatch is proud to announce the availability of two new datasets: Bulk API Sources and Clinical Trials. The addition of Bulk API sources complements the existing Suppliers / Packagers dataset. While the Suppliers / Packagers provides information where to source on finished products, the Bulk API Sources lists […]




Click here for reuse options!
Copyright 2017 Biotechblog

FDA Orange Book Archives

Approved Drug Products With Therapeutic Equivalance Evaluations In addition to its deep database of global drug and patent information, DrugPatentWatch also has archives of the Food and Drug Administration (FDA) Orange Book, or Approved Drug Products With Therapeutic Equivalence Evaluationscatalogs. The Orange Book identifies drug products approved on the basis of safety and effectiveness by […]




Click here for reuse options!
Copyright 2016 Biotechblog

Brexit and British Biotech

I have a tool that can be used to measure the impact of Brexit on biotechnology in the United Kingdom. I have been measuring global biotechnology for eight years and my objective data-driven metrics provide both a baseline to gauge future directions, and guidance for how to improve the sector’s performance. Eight years ago I […]




Click here for reuse options!
Copyright 2016 Biotechblog

FDA Orange Book Archives From 1980 to Present

The Food and Administration (FDA) Orange Book, or Approved Drug Products With Therapeutic Equivalence Evaluations, is an authoritative list of patents covering branded drugs, and of generic equivalents. The Orange Book identifies drug products approved on the basis of safety and effectiveness by the FDA under the Federal Food, Drug, and Cosmetic Act. Each edition includes […]




Click here for reuse options!
Copyright 2016 Biotechblog

Book signing sold out at #BIO2016

My book signing sold out, but do not despair — you can still get a signed copy. Signed copies of Building Biotechnology can be purchased at http://www.BuildingBiotechnology.com , and you can also get regular copies at Amazon. This acclaimed book describes the convergence of scientific, political, regulatory, and commercial factors that drive the biotechnology industry and define […]




Click here for reuse options!
Copyright 2016 Biotechblog

When do Drug Patents Expire, and When Can Generic Drugs Launch?

When do drug patents expire, and when can generic drugs launch? An overview of patents, non-patent regulatory exclusivities, and specific US and EU factors influencing generic drug launch.




Click here for reuse options!
Copyright 2016 Biotechblog

Scientific American Worldview Issue 6 at #BIO2014

I continue to measure global biotechnology innovation in the sixth edition of Scientific American Worldview. This special publication is the foundation I use for my talks on global biotechnology (see my recent talk on Building Biotechnology in India). I will be serving on a panel on June 26th at 12:45-1:45 in Room 3, and David Brancaccio, host of […]




Click here for reuse options!
Copyright 2014 Biotechblog

%d bloggers like this: